Clinical case of angiosarcoma of pericardium and pleura
pdf (Русский)

Keywords

angiosarcom
heart tumors

How to Cite

Sobinov, D., Zakharian, E., Balamutova, A., & Litvinov, D. (2021). Clinical case of angiosarcoma of pericardium and pleura. Voprosy Onkologii, 67(6), 846–848. https://doi.org/10.37469/0507-3758-2021-67-6-846-848

Abstract

Primary heart tumors are an extremely rare pathology, previously detected only by autopsy data and detected in 0.001%-0.03% of cases. Primary angiosarcomas of the pericardium are even more rare and are presented in the literature with isolated descriptions. The article describes a clinical case of epithelioid angiosarcoma of the pericardium and pleura of high malignancy in a 57-year-old man. The diagnosis was confirmed by immunohistochemical examination and positron emission tomography. For today, chemotherapeutic treatment of angiosarcomas localized in the chest cavity is a palliative treatment method. In this patient, the most effective scheme was the one containing anthracyclines (doxorubicin). Despite the ongoing therapy, the patient died 15 months after the diagnosis was made, with increasing signs of respiratory and heart failure. Thus, when patients, especially young and middle-aged men, show signs of hydropericardium without established etiological prerequisites, it is necessary to remember about the possibility of developing a primary malignant tumor of the heart and / or pericardium as the cause of this condition and include it in the standard diagnostic search.

https://doi.org/10.37469/0507-3758-2021-67-6-846-848
pdf (Русский)

References

Burke AP, Virmani R. Tumors of the heart and great vessels. In: Rosai J, Sobin LH, eds. Atlas of Tumor Pathology. Third series, fascicle 16. Armed Forces Institute of Pathology. Washington, DC, 1996.

Isambert N et al. Primary cardiac sarcomas: A retrospective study of the French Sarcoma Group // European Journal of Cancer. 2014;50(1):128–136. doi:10.1016/j.ejca.2013.09.012

Kajihara N. et al. Surgical Experience of Cardiac Tumors: Early and Late Results // Surgery Today. 2006;36(7):602–607. doi:10.1007/s00595-006-3217-6

McAllister HA, Fenoglio JJ, Fine G. 1980. Tumors of the Cardiovascular System. (Atlas of Tumor Pathology, Second Series, Fascicle 15.) // The American Journal of Surgical Pathology. 1980;4(3):306. doi:10.1097/00000478-198006000-00017

Ong P. et al. Favorable Course of Pericardial Angiosarcoma Under Paclitaxel Followed by Pazopanib Treatment Documented by Cardiovascular Magnetic Resonance Imaging // Circulation. 2012;126(18). doi:10.1161/circulationaha.112.128348

Patel J, Sheppard MN. Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy series // Cardiovascular Pathology. 2010;19(6):343–352. doi:10.1016/j.carpath.2009.07.005

Penel N et al. Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study // Journal of Clinical Oncology. 2008;26(32):5269–5274. doi:10.1200/jco.2008.17.3146

Primary angiosarcoma of the pericardium: case report and review of the literature // Kardiol Pol. 2010;68(7): 802–805.

Ram Prabu MP et al. Primary Cardiac Angiosarcoma with Good Response to Paclitaxel // Journal of Thoracic Oncology. 2011;6(10):1778–1779. doi:10.1097/jto.0b013e31822e2973

Shukkur A, Buresly K, Uthaman B. Unusual survival time of primary cardiac sarcoma of the right ventricle // Heart Views. 2011;12(1):35. doi:10.4103/1995-705x.81552

Walley VM, Masters RG. Pericardial angiosarcoma and associated hemorrhage // The Annals of Thoracic Surgery. 1994;57(1):259–260. doi:10.1016/0003-4975(94)90424-3

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2021